Myelodysplastic syndrome treatment with danazol and cis‐retinoic acid
Authors:
- 1 April 1995
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 48 (4) , 233-236
Abstract
We prospectively treated 46 patients with favorable myelodysplastic syndrome classified as refractory anemia (RA), refractory cytopenia (RC), or refractory anemia with ringed sideroblasts (RARS). These patients received one of two schedules of 13‐Cis‐Retinoic Acid (low dose 80 mg daily for 6 months vs. high dose 200 mg po daily for 3 months), or Danazol (800 mg po daily for 3 months), and were crossed over to the alternative drug in the absence of response or at progression.Using strict criteria of response we found little objective evidence of activity for either compound. Only two minor responses were seen among 22 patients treated with low dose 13‐CRA, 1 response among 20 cases that received high dose 13‐CRA, and 1 partial response and 1 minor response to Danazol among 34 cases.Neither 13‐Cis‐Retinoic Acid nor Danazol appear active enough in patients with favorable myelodysplastic syndrome to justify their use.Keywords
This publication has 13 references indexed in Scilit:
- EFFECT OF 13-cis-RETINOIC ACID ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROMEThe Lancet, 1987
- Preleukaemia: A long‐term prospective study of 326 patientsScandinavian Journal of Haematology, 1986
- Prognostic factors in the myelodysplastic syndromes: A reviewScandinavian Journal of Haematology, 1986
- Danazol Therapy in MyelodysplasiaAnnals of Internal Medicine, 1985
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Allogeneic Marrow Transplantation in the Treatment of PreleukemiaAnnals of Internal Medicine, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.Proceedings of the National Academy of Sciences, 1980
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976